Epilepsy
📧 Sign up to get email alerts when something new happens for Epilepsy.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2014-12-30FDA Approved: LAMICTAL XR — Supplemental Application (GlaxoSmithKline LLC)
The FDA approved a supplemental application for LAMICTAL XR (lamotrigine) from GlaxoSmithKline LLC, updating the extended-release formulatio…
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: Intraoral 30% Glucose Effect In Newborns [Phase 3]
A Phase 3 trial evaluating intraoral 30% glucose in newborns has completed, investigating effects in epilepsy and hydrocephaly.
-
CLINICAL_TRIALS trial_result · 2014-12-30Clinical Trial Update: A Study to Evaluate the Tolerability and Pharmacokinetics of Two Single and Multiple High Dose Regimens of BIA 2-093 In Healthy Volunteers [Phase 1]
Phase 1 study evaluating tolerability and pharmacokinetics of single and multiple high-dose regimens of the epilepsy drug candidate BIA 2-09…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: Trial to Evaluate the Effect of Eslicarbazepine Acetate on Cardiac Repolarization [Phase 1]
Phase 1 trial evaluating whether eslicarbazepine acetate affects cardiac repolarization in epilepsy patients; the study completed and result…
-
CLINICAL_TRIALS trial_result · 2014-12-22Clinical Trial Update: A Open-label, Drug Interaction Study Between Eslicarbazepine Acetate and Topiramate [Phase 1]
Open-label Phase 1 trial evaluating the drug interaction between eslicarbazepine acetate and topiramate in epilepsy; the study has completed…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-12-19Clinical Trial Update: A Sequential Multiple Ascending Dose Study of the Safety and Pharmacokinetics of Eslicarbazepine Acetate in Adult Healthy Volunteers [Phase 1]
Phase 1 study assessing safety and pharmacokinetics of sequentially escalating doses of eslicarbazepine acetate in healthy adult volunteers.
-
CLINICAL_TRIALS trial_result · 2014-12-18Clinical Trial Update: Open-label Drug Interaction Study Between Eslicarbazepine Acetate and Phenytoin. [Phase 1]
An open-label Phase 1 trial assessed the drug interaction between eslicarbazepine acetate and phenytoin in epilepsy, with results posted.
-
CLINICAL_TRIALS research · 2014-12-17Clinical Trial Update: Efficacy Study of Folic Acid Supplementation in Adolescent Epileptics [Phase 3]
Phase 3 clinical trial update evaluating folic acid supplementation in adolescents with epilepsy; no results are reported and the trial stat…
-
FDA approval · 2014-12-13FDA Approved: LAMOTRIGINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for Lamotrigine by Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2014-12-12FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lamotrigine from Aurobindo Pharma Limited, reflecting changes to labeling for this generic produ…
-
CLINICAL_TRIALS trial_result · 2014-12-12Clinical Trial Update: The Tolerability and Effect of Food on the Pharmacokinetics of a Single 800 mg Oral Dose of BIA 2-093 [Phase 1]
This Phase 1 trial evaluated tolerability and how food affects the pharmacokinetics of a single 800 mg oral dose of BIA 2-093 in epilepsy.
-
FDA approval · 2014-12-12FDA Approved: LAMOTRIGINE — Supplemental Application (Alembic Pharmaceuticals Limited)
FDA approved a supplemental application for lamotrigine from Alembic Pharmaceuticals Limited under an ANDA. This confirms approval of a supp…
-
FDA approval · 2014-12-11FDA Approved: LEVETIRACETAM — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for levetiracetam from Sun Pharmaceutical Industries, Inc.
-
FDA approval · 2014-12-10FDA Approved: LAMOTRIGINE — Supplemental Application (Unichem Pharmaceuticals (USA), Inc.)
FDA granted a supplemental approval for Lamotrigine from Unichem Pharmaceuticals (USA), Inc. under an ANDA supplemental application. The sni…
-
FDA approval · 2014-12-10FDA Approved: LAMOTRIGINE KIT — Supplemental Application (OWP Pharmaceuticals, Inc.)
FDA approved a supplemental application to authorize a Lamotrigine Kit from OWP Pharmaceuticals, Inc., expanding the approved lamotrigine pr…
-
FDA approval · 2014-12-10FDA Approved: LAMOTRIGINE — Supplemental Application (Jubilant Cadista Pharmacuticals Inc.)
FDA approved a supplemental application for lamotrigine from Jubilant Cadista Pharmaceuticals Inc. This marks an approval of a generic lamot…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function [Phase 1]
Phase 1 study investigating the effects of eslicarbazepine acetate (BIA 2-093) on cognition and psychomotor function in epilepsy patients; r…
-
CLINICAL_TRIALS trial_result · 2014-12-10Clinical Trial Update: Single Dose Crossover Comparative Bioavailability Study of Eslicarbazepine Acetate Versus To-be-marketed Formulation [Phase 1]
Phase 1 single-dose crossover study compared the bioavailability of eslicarbazepine acetate to a to-be-marketed formulation in epilepsy; res…
-
CLINICAL_TRIALS withdrawal · 2014-12-10Clinical Trial Update: Study of Phenobarbital Inhibition of Catamenial Epilepsy [NA]
The study evaluating phenobarbital for catamenial epilepsy has been withdrawn from clinical trials, with no current recruitment or results a…
-
FDA approval · 2014-12-09FDA Approved: LEVETIRACETAM — Supplemental Application (Patrin Pharma, Inc.)
FDA approved a supplemental application for Patrin Pharma's levetiracetam, a generic anticonvulsant used to treat epilepsy.
-
FDA approval · 2014-12-09FDA Approved: ONFI — Supplemental Application (Lundbeck Pharmaceuticals LLC)
FDA approved a supplemental application for ONFI (clobazam) from Lundbeck Pharmaceuticals LLC. The approval updates the labeling for ONFI, p…
-
CLINICAL_TRIALS trial_result · 2014-12-08Clinical Trial Update: Study of Human Sensory Perception
This entry reports a completed clinical trial update for a study on human sensory perception sponsored by Swedish Medical Center in people w…
-
FDA approval · 2014-12-05FDA Approved: LAMOTRIGINE — Supplemental Application (Aurobindo Pharma Limited)
FDA approved a supplemental application for lamotrigine by Aurobindo Pharma Limited, authorizing changes to an existing lamotrigine product.
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Disposition of Eslicarbazepine Acetate and Its Metabolites S-licarbazepine and R-licarbazepine [Phase 1]
Phase 1 trial update reporting the disposition of eslicarbazepine acetate and its metabolites S-licarbazepine and R-licarbazepine, with resu…
-
CLINICAL_TRIALS trial_result · 2014-12-03Clinical Trial Update: Effect of BIA 2-093 on the Pharmacokinetics of a Combined Oral Contraceptive. [Phase 1]
Phase 1 trial evaluating the effect of BIA 2-093 on the pharmacokinetics of a combined oral contraceptive; results were posted.